A study for the usefulness of blood glycated albumin measurement by delivery

A study for the usefulness of blood glycated albumin measurement by delivery - A study for the usefulness of blood glycated albumin measurement by delivery

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046088

Enrollment

120

Registered

2021-11-19

Start date

2021-11-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

No blood glycated albumin measurement by delivery is taken in this group blood glycated albumin measurement by delivery (every week, for 3 months) in this group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men and women over 20 years old, type 2 diabetic patients with HbA1c of 6.5% or more

Exclusion criteria

Exclusion criteria: HbA1c level less than 6.5%, HIV, hepatitis B, hepatitis C, syphilis positive in infectious disease test, insulin use

Design outcomes

Primary

Measure	Time frame
HbA1c level, glycated albumin level, fasting blood glucose level	—

Secondary

Measure	Time frame
body weight, waist circumference, Inbody, lipids, liver/kidney function, questionnaires	—

Countries

Japan

Contacts

Public ContactMASAKAZU AIHARA

Graduate School of Medicine, The University of Tokyo Department of Diabetes and Metabolic Diseases

maihara-tky@umin.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026